Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 06, 2016
Capsugel has completed its acquisitions of Xcelience and Powdersize. Xcelience and Powdersize are now part of Capsugel's Dosage Form Solutions business unit, which partners with pharmaceutical and health and nutrition customers around the world.
read more
Capsugel today announced an agreement with Chiasma, Inc., wherein Capsugel’s Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only investigational oral form of octreotide in clinical development. The drug candidate is in ...
read more
Capsugel has developed a technology that makes its vegetarian, acid-resistant DRcaps™ hard capsules suitable for liquid-fill applications.
read more
Capsugel's offering combines its proprietary Xcelodose® Precision Powder Micro-Dosing Systems with industry-leading powder-in-capsule/powder-in-bottle (PIC/PIB) expertise developed at Xcelience, which Capsugel acquired in January.
read more
Wednesday, September 07, 2016
Capsugel has announced an expansion of its facility in Quakertown, Pa., to meet increasing customer demand for its micronization services for both clinical and commercial manufacturing.
read more
Tuesday, September 27, 2016
After successfully completing four transformational acquisitions, as well as several other strategic investments, Capsugel has announced that it has unified them all under one brand and unveiled a new corporate campaign that highlights the company’s ...
read more
Thursday, October 29, 2015
Capsugel has announced the global commercial launch of its enTRinsicTM drug delivery technology platform.
read more
Thursday, September 05, 2013
Capsugel and Bend Research announced today that they have entered into a definitive agreement for Capsugel to acquire Bend Research as part of its Dosage Form Solutions (DFS) business unit. The acquisition provides Capsugel DFS an industry leading ...
read more
Monday, December 14, 2015
Capsugel, Xcelience and Powdersize announced today that the three companies have entered into a definitive agreement under which Capsugel will acquire both Xcelience and Powdersize.
read more
Capsugel has completed construction of a new pharmaceutical spray-dried dispersion (SDD) commercial manufacturing facility at its site in Bend, Oregon.
read more
Wednesday, October 31, 2018
Capua BioServices has announced the completion of the renovation of one of the recovery and purification plants, at its facility in Capua, Italy.
read more
CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced a strategic co-investment of more than CHF 25 million with a long-standing Japanese customer to expand ...
read more
CARBOGEN AMCIS, a Swiss-based company offering process development and manufacturing of Active Pharmaceutical Ingredients (APIs) to the pharmaceutical industry, has announced the extension of its operations in Bubendorf.
read more
Switzerland-based CARBOGEN AMCIS announced the successful completion of the first inspection by the French regulatory authority, ANSM (Agence nationale de sécurité du médicament et des produits de santé), at its state-of-the-art sterile drug product ...
read more
Monday, September 28, 2026
CARBOGEN AMCIS said its Vionnaz, Switzerland, facility completed its first FDA pre-approval inspection without receiving a Form 483.
read more